Amber List

KODKodiak Sciences Inc

Healthcare · Biotechnology · small-cap ($1.4B)
-24.5%
from rolling 252-day high of $47.84 set 2026-04-22 · 36d ago
Current
$36.12
Decline depth
-24.5%
Decline σ
7.2σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$KOD landed on the list 2026-03-08, down 17.5% from its 52-week high that day — now down -24.5%.

It has clawed back 18.2 percentage points off that level. It bottomed 29.9% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-09 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

KOD qualifies for the Amber List on decline depth.

Decline depth
-24.5%
From rolling 252-day high of $47.84, 36d ago. Past the 20% Watch threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
7.2σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.61% per day). Past the ≥6σ Amber threshold.

The structural read

What price action says about KOD.

KOD qualifies for the Amber List on decline depth — down -24.5% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 7.2σ over 20 bars.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 1 (green), weekly 1 (red), monthly 2D (red).

52-week range

52W low $1.92 100.0% of range 52W high $31.18

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
46 Amber
59 Watch
-36.0% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about KOD

What people ask.

Why is KOD on Broken Stocks?

KOD qualifies for the Amber List on decline depth. It is down -24.5% from its rolling 252-day high of $47.84, set on 2026-04-22 — 36d ago.

Is KOD a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. KOD is down -24.5% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is KOD a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is KOD trading inside its 52-week range?

At $36.12, KOD sits 100.0% of the way from its 52-week low ($1.92) to its 52-week high ($31.18). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has KOD been declining?

The current 24.5% decline accrued over 36d, which annualizes to roughly -248.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does KOD compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -36.0% — KOD's decline is shallower than the sector median.